LOGIN
Topical Lozoprofen Around Incision on Postoperative Pain After Transforaminal Lumbar Fusion Surgery
February 2024
Topical Lozoprofen Around Incision on Postoperative Pain After Transforaminal Lumbar Fusion Surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Effect of Topical Nonsteroidal Anti-inflammatory Drugs Around the Incision on Postoperative Pain in Transforaminal Lumbar Interbody Fusion Surgery: A Double-blind Randomized Controlled Trial.
Pain Physician . 2023 Sep;26(5):467-473.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
80 patients undergoing transforaminal lumbar interbody fusion (TLIF) for degenerative lumbar disease were randomized to receive either lozoprofen (n=40) or a placebo (n=40). The primary outcome of interest included pain on a Visual Analog Scale (VAS) for up to 72 hours and sufentanil consumption for up to 48 hours. The secondary outcomes of interest included time to first analgesic request, incide...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.